Could immune checkpoints PD-1/PD-L1, PD-L2 and CTLA-4 be valuable in the spontaneous canine model of breast cancer?
1/5 보강
Immunotherapy has emerged as an auspicious new therapeutic modality in oncology, with immune checkpoint inhibitors showing promising results on several malignancies.
APA
Monteiro M, Santos M, Santos A (2025). Could immune checkpoints PD-1/PD-L1, PD-L2 and CTLA-4 be valuable in the spontaneous canine model of breast cancer?. Critical reviews in oncology/hematology, 216, 104973. https://doi.org/10.1016/j.critrevonc.2025.104973
MLA
Monteiro M, et al.. "Could immune checkpoints PD-1/PD-L1, PD-L2 and CTLA-4 be valuable in the spontaneous canine model of breast cancer?." Critical reviews in oncology/hematology, vol. 216, 2025, pp. 104973.
PMID
41033595 ↗
Abstract 한글 요약
Immunotherapy has emerged as an auspicious new therapeutic modality in oncology, with immune checkpoint inhibitors showing promising results on several malignancies. Immune checkpoint molecules, such as PD-1 and its ligands (PD-L1 and PD-L2) and CTLA-4 represent a physiological mechanism to downregulate immune activity. This pathway seems to be used by different tumors to evade immune system and suppressing tumor-specific immune responses. Immune checkpoints expression in some tumors is related to higher malignancy and poor prognosis. The association of immune checkpoints with worst outcome has also been established specifically in human breast cancer. The evaluation of the role of immune checkpoints in canine mammary tumors is still very incipient. Therefore, further research will be needed in this field in order to provide new treatment and diagnosis targets and predictive factors with potential benefit for both human and animals. Herein, we provide an updated narrative review of the role of immune checkpoints in canine mammary tumors in comparison with breast cancer, emphasizing recent advances and the translational relevance of these pathways in comparative oncology.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- SpNeigh: spatial neighborhood and differential expression analysis for high-resolution spatial transcriptomics.
- Key Considerations for Targeting in Pancreatic Cancer: Potential Impact on the Treatment Paradigm.
- The tumor microenvironment as a key regulator of radiotherapy response.
- Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.
- Advances in green-synthesized magnetic nanoparticles for targeted cancer therapy: mechanisms, applications, and future perspectives.
- SMURF2 in Anticancer Therapy: Dual Role in Carcinogenesis and Theranostics.